Related Experiment Video

Updated: Aug 1, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

[Genetic variations of hepatitis C virus circulating in the Ural region]

S Iu Kovalev, O I Maliushenko, N P Glinskikh

    Voprosy Virusologii
    |November 6, 2003
    PubMed

    Insights

    Hepatitis C virus (HCV) subtype distribution varies by age and location in Russia. Subtype 1b predominates in clinical settings, while subtype 3a is more common in younger individuals, linked to drug use.

    Area of Science:

    • Virology
    • Epidemiology
    • Public Health

    Background:

    • Hepatitis C virus (HCV) exhibits diverse genetic subtypes globally.
    • Understanding subtype distribution is crucial for effective treatment and prevention strategies.
    • Previous studies have characterized HCV subtypes in major Russian cities like Moscow and Saint Petersburg.

    Purpose of the Study:

    • To investigate the distribution of HCV genetic subtypes in Yekaterinburg and Chelyabinsk.
    • To analyze subtype prevalence across different age groups and social statuses.
    • To identify factors influencing observed subtype patterns.

    Main Methods:

    • Retrospective analysis of HCV subtype data from infected populations in Yekaterinburg and Chelyabinsk.
    • Comparison of subtype frequencies in hemodialysis and pediatric oncohematology centers.
    • Stratification of data by age groups and geographical location.

    Main Results:

    • Subtype 1b was predominant (83.3-84.6%) in patients at hemodialysis and pediatric oncohematology centers.
    • In Chelyabinsk, subtype 1b was twice as prevalent as 3a; in Yekaterinburg, the ratio was 1:1.
    • Subtype 3a was more prevalent in the 15-27 age group, while 1b dominated in those younger than 15 and older than 27.

    Conclusions:

    • HCV subtype distribution shows significant geographical and age-related variations within the Urals region.
    • The increasing prevalence of subtype 3a in younger populations is linked to a rise in young intravenous drug users.
    • These findings highlight the need for targeted public health interventions for specific demographics and regions.

    More Related Videos

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

    Published on: June 26, 2020

    Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers07:58

    Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers

    Published on: May 22, 2026

    Related Concept Videos

    Viral Mutations00:36

    Viral Mutations

    A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
    Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

    Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

    Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
    Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

    Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

    Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
    Genetic Variation01:25

    Genetic Variation

    Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
    Genes exist in different versions called alleles, which...
    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...